Reprint

Extracellular Chaperones and Related miRNA as Diagnostic Tools of Chronic Diseases

Edited by
October 2021
168 pages
  • ISBN978-3-0365-2148-0 (Hardback)
  • ISBN978-3-0365-2147-3 (PDF)

This book is a reprint of the Special Issue Extracellular Chaperones and Related miRNA as Diagnostic Tools of Chronic Diseases that was published in

Biology & Life Sciences
Chemistry & Materials Science
Computer Science & Mathematics
Engineering
Environmental & Earth Sciences
Physical Sciences
Summary

The aim of this book is to collect breakthrough papers focusing on data supporting the view that extracellular chaperones and their related miRNA (including either those in their soluble form or those hosted in extracellular vesicles) may represent an innovative diagnostic tool in many chronic human pathologies. We will particularly focus on papers that—other than presenting solid data on the aforementioned aim—also discuss original data about mechanistic roles of these molecules inside and outside cells.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
exosomes; adipose-derived stem cell released exosomes; tumor-derived exosomes; metabolic diseases; mesenchymal stem cells; exosomes; heat shock proteins; cancer; adolescents and young adults; AYA; brain tumors; extracellular vesicles; miRNA; molecular chaperones; diagnostic tools; drug delivery; pediatric multiple sclerosis; microRNA; gene target; high-throughput next-generation sequencing; chaperone system; molecular chaperones; Alzheimer’s disease; Parkinson’s disease; Huntington’s disease; amyotrophic lateral sclerosis; multiple sclerosis; chaperonotherapy; chaperonopathies; chaperone system; molecular chaperones; chaperonopathies; nervous system; neurochaperonopathies; Hsps; neurodegeneration; neuromuscular disorders; chaperonotherapy; Hsp60; chaperonopathies; carcinogenesis; extracellular vesicle (EV); miRNA; chaperonotherapy; chaperone system; molecular chaperones; chaperonopathies; Hsp60; miRNAs; extracellular vesicles; high-grade glioma; glioblastoma; meningioma; liquid biopsy; tumor biomarkers; n/a